GABAergic inhibition sharpens the frequency tuning and enhances phase locking in chicken nucleus magnocellularis neurons.
GABAergic modulation of activity in avian cochlear nucleus neurons has been studied extensively in vitro. However, how this modulation actually influences processing in vivo is not known. We investigated responses of chicken nucleus magnocellularis (NM) neurons to sound while pharmacologically manipulating the inhibitory input from the superior olivary nucleus (SON). SON receives excitatory inputs from nucleus angularis (NA) and nucleus laminaris (NL), and provides GABAergic inputs to NM, NA, NL, and putatively to the contralateral SON. Results from single-unit extracellular recordings from 2 to 4 weeks posthatch chickens show that firing rates of auditory nerve fibers increased monotonically with sound intensity, while that of NM neurons saturated or even decreased at moderate or loud sound levels. Blocking GABAergic input with local application of TTX into the SON induced an increase in firing rate of ipsilateral NM, while that of the contralateral NM decreased at high sound levels. Moreover, local application of bicuculline to NM also increased the firing rate of NM neurons at high sound levels, reduced phase locking, and broadened the frequency-tuning properties of NM neurons. Following application of DNQX, clear evidence of inhibition was observed. Furthermore, the inhibition was tuned to a broader frequency range than the excitatory response areas. We conclude that GABAergic inhibition from SON has at least three physiological influences on the activity of NM neurons: it regulates the firing activity of NM units in a sound-level-dependent manner; it improves phase selectivity; and it sharpens frequency tuning of NM neuronal responses.
Fukui
Iwao
I
Department of Physiology and Neurobiology, Faculty of Medicine, Kyoto University, Kyoto, Japan. fukui@nbiol.med.kyoto-u.ac.jp
Burger
R Michael
RM
Ohmori
Harunori
H
Rubel
Edwin W
EW
D000161:Acoustic Stimulation / Q000379:methods; D000200:Action Potentials / Q000187:drug effects / Q000502:physiology*; D000704:Analysis of Variance; D000818:Animals; D000831:Animals, Newborn; D001640:Bicuculline / Q000494:pharmacology; D002645:Chickens / Q000033:anatomy & histology; D017626:Cochlear Nucleus / Q000166:cytology*; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D007839:Functional Laterality; D018756:GABA Antagonists / Q000494:pharmacology; D009433:Neural Inhibition / Q000187:drug effects / Q000502:physiology*; D009474:Neurons / Q000145:classification / Q000166:cytology* / Q000187:drug effects; D011571:Psychoacoustics; D011810:Quinoxalines / Q000494:pharmacology; D026941:Sodium Channel Blockers / Q000494:pharmacology; D013779:Tetrodotoxin / Q000494:pharmacology; D013997:Time Factors; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D018691:Excitatory Amino Acid Antagonists; D018756:GABA Antagonists; D011810:Quinoxalines; D026941:Sodium Channel Blockers; D013779:Tetrodotoxin; D005680:gamma-Aminobutyric Acid; C056723:FG 9041; D001640:Bicuculline
Neuron. 1997 Nov;19(5):959-62
9390510
Curr Opin Neurobiol. 1997 Aug;7(4):487-92
9287194
J Otolaryngol. 1995 Feb;24(1):20-30
7769641
J Neurosci. 2008 Jul 9;28(28):7153-64
18614685
J Neurosci. 1983 Jul;3(7):1373-8
6864252
Annu Rev Neurosci. 2003;26:31-55
14527266
Neuroscience. 1982 Apr;7(4):809-36
7099420
J Neurosci. 1994 Sep;14(9):5352-64
8083740
J Comp Neurol. 1978 Aug 1;180(3):439-48
659669
J Neurosci. 1990 Oct;10(10):3227-46
2213141
Neurosci Res. 2010 Feb;66(2):198-212
19914308
J Neurosci. 2001 Mar 15;21(6):1857-67
11245670
J Neurophysiol. 2006 Aug;96(2):633-41
16687616
J Neurosci. 2002 Dec 15;22(24):11004-18
12486196
J Comp Neurol. 1994 Oct 15;348(3):403-18
7844255
J Neurosci. 2004 Aug 25;24(34):7514-23
15329398
J Comp Neurol. 2005 Jan 3;481(1):6-18
15558730
J Physiol. 2001 Aug 15;535(Pt 1):125-31
11507163
J Comp Neurol. 2005 Aug 15;489(1):11-22
15977167
J Comp Neurol. 1991 Dec 8;314(2):306-18
1723997
J Neurosci. 1988 Aug;8(8):2665-76
3411346
Nat Rev Neurosci. 2003 Jul;4(7):540-50
12838329
J Comp Neurol. 1990 Nov 22;301(4):643-54
2273102
J Neurophysiol. 2008 Mar;99(3):1077-95
18199821
J Comp Physiol A. 1990 Mar;166(5):721-34
2341992
J Neurosci. 2001 Oct 1;21(19):7823-30
11567073
J Neurosci. 2001 Dec 1;21(23):9487-98
11717383
J Neurophysiol. 2005 Jul;94(1):400-14
15744007
J Comp Neurol. 1989 Aug 8;286(2):190-207
2794115
J Neurosci. 2010 Sep 8;30(36):12063-74
20826669
J Neurophysiol. 1994 Nov;72(5):2124-33
7884448
J Comp Physiol A. 1992 Feb;170(2):227-41
1583607
J Neurosci. 2000 Apr 15;20(8):2954-63
10751448
J Neurosci. 1999 Mar 15;19(6):2313-25
10066281
Neuroscience. 1982 Apr;7(4):855-70
7099422
J Neurosci. 2007 Feb 21;27(8):2112-23
17314306
J Comp Neurol. 1989 Jun 22;284(4):504-18
2768549
J Neurophysiol. 1969 Jul;32(4):613-36
5810617
Electroencephalogr Clin Neurophysiol. 1980 Feb;48(2):249-51
6153344
Neuroscience. 1981;6(11):2351-65
7329551
J Neurosci. 1992 May;12(5):1698-708
1578264
J Neurophysiol. 1998 Dec;80(6):2824-35
9862887
Neuroscience. 1982 Apr;7(4):837-53
7099421